Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.

Ruan Q, D'Onofrio G, Sancarlo D, Greco A, Yu Z.

Mol Med Rep. 2016 Oct;14(4):3184-98. doi: 10.3892/mmr.2016.5618. Epub 2016 Aug 9. Review.

2.

Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.

Racine AM, Koscik RL, Berman SE, Nicholas CR, Clark LR, Okonkwo OC, Rowley HA, Asthana S, Bendlin BB, Blennow K, Zetterberg H, Gleason CE, Carlsson CM, Johnson SC.

Brain. 2016 Aug;139(Pt 8):2261-74. doi: 10.1093/brain/aww142. Epub 2016 Jun 20.

PMID:
27324877
3.

Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.

Ruan Q, D'Onofrio G, Sancarlo D, Bao Z, Greco A, Yu Z.

BMC Geriatr. 2016 May 16;16:104. doi: 10.1186/s12877-016-0281-7.

4.

Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling.

Minkova L, Scheller E, Peter J, Abdulkadir A, Kaller CP, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S; TrackOn-HD Investigators..

Front Hum Neurosci. 2015 Nov 25;9:634. doi: 10.3389/fnhum.2015.00634. eCollection 2015.

5.

Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.

Chung JK, Plitman E, Nakajima S, Chakravarty MM, Caravaggio F, Gerretsen P, Iwata Y, Graff-Guerrero A; Alzheimer’s Disease Neuroimaging Initiative..

J Geriatr Psychiatry Neurol. 2016 May;29(3):149-59. doi: 10.1177/0891988715606230. Epub 2015 Sep 23. Erratum in: J Geriatr Psychiatry Neurol. 2016 Jul;29(4):237-41.

6.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005. Review.

7.

The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding.

Beckett LA, Donohue MC, Wang C, Aisen P, Harvey DJ, Saito N; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2015 Jul;11(7):823-31. doi: 10.1016/j.jalz.2015.05.004. Review.

8.

Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.

Jack CR Jr, Barnes J, Bernstein MA, Borowski BJ, Brewer J, Clegg S, Dale AM, Carmichael O, Ching C, DeCarli C, Desikan RS, Fennema-Notestine C, Fjell AM, Fletcher E, Fox NC, Gunter J, Gutman BA, Holland D, Hua X, Insel P, Kantarci K, Killiany RJ, Krueger G, Leung KK, Mackin S, Maillard P, Malone IB, Mattsson N, McEvoy L, Modat M, Mueller S, Nosheny R, Ourselin S, Schuff N, Senjem ML, Simonson A, Thompson PM, Rettmann D, Vemuri P, Walhovd K, Zhao Y, Zuk S, Weiner M.

Alzheimers Dement. 2015 Jul;11(7):740-56. doi: 10.1016/j.jalz.2015.05.002.

9.

Monitoring the early signs of cognitive decline in elderly by computer games: an MRI study.

Sirály E, Szabó Á, Szita B, Kovács V, Fodor Z, Marosi C, Salacz P, Hidasi Z, Maros V, Hanák P, Csibri É, Csukly G.

PLoS One. 2015 Feb 23;10(2):e0117918. doi: 10.1371/journal.pone.0117918. eCollection 2015.

10.

Multimodality imaging of Alzheimer disease and other neurodegenerative dementias.

Nasrallah IM, Wolk DA.

J Nucl Med. 2014 Dec;55(12):2003-11. doi: 10.2967/jnumed.114.141416. Epub 2014 Nov 20. Review.

11.

Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease.

Bertens D, Knol DL, Scheltens P, Visser PJ; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2015 May;11(5):511-22. doi: 10.1016/j.jalz.2014.05.1754. Epub 2014 Aug 20.

12.

Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria.

Ferreira D, Perestelo-Pérez L, Westman E, Wahlund LO, Sarría A, Serrano-Aguilar P.

Front Aging Neurosci. 2014 Mar 24;6:47. doi: 10.3389/fnagi.2014.00047. eCollection 2014. Review.

13.

Biological heterogeneity in ADNI amnestic mild cognitive impairment.

Nettiksimmons J, DeCarli C, Landau S, Beckett L; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2014 Sep;10(5):511-521.e1. doi: 10.1016/j.jalz.2013.09.003. Epub 2014 Jan 10.

14.

A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.

Braskie MN, Thompson PM.

Biol Psychiatry. 2014 Apr 1;75(7):527-33. doi: 10.1016/j.biopsych.2013.11.020. Epub 2013 Nov 28. Review.

15.

Latent feature representation with stacked auto-encoder for AD/MCI diagnosis.

Suk HI, Lee SW, Shen D; Alzheimer’s Disease Neuroimaging Initiative..

Brain Struct Funct. 2015 Mar;220(2):841-59. doi: 10.1007/s00429-013-0687-3. Epub 2013 Dec 22.

16.

Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

Braskie MN, Thompson PM.

Trends Cogn Sci. 2013 Oct;17(10):510-6. doi: 10.1016/j.tics.2013.08.007. Epub 2013 Sep 9. Review.

17.

Modular reorganization of brain resting state networks and its independent validation in Alzheimer's disease patients.

Chen G, Zhang HY, Xie C, Chen G, Zhang ZJ, Teng GJ, Li SJ.

Front Hum Neurosci. 2013 Aug 9;7:456. doi: 10.3389/fnhum.2013.00456. eCollection 2013.

18.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Shen L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2013 Sep;9(5):e111-94. doi: 10.1016/j.jalz.2013.05.1769. Epub 2013 Aug 7. Review.

19.

Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage.

Nettiksimmons J, Beckett L, Schwarz C, Carmichael O, Fletcher E, Decarli C.

Psychol Aging. 2013 Mar;28(1):191-201. doi: 10.1037/a0031063.

20.

Measuring abnormal brains: building normative rules in neuroimaging using one-class support vector machines.

Sato JR, Rondina JM, Mourão-Miranda J.

Front Neurosci. 2012 Dec 13;6:178. doi: 10.3389/fnins.2012.00178. eCollection 2012.

Supplemental Content

Support Center